SEC Form 4 · accession 0000919574-15-004947
NOVELION THERAPEUTICS INC. · NVLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
AXIAL CAPITAL MANAGEMENT, LLC
10% Owner
Eliav Assouline
10% Owner
Marc Andersen
10% Owner
Period of report
Jun 16, 2015
Accepted (ET)
Jun 17, 2015 · 11:20 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827809
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Jun 16, 2015 | S | 8,865,036 | $3.4711 | D | 0 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported securities are directly owned by certain private investment vehicles managed by Axial Capital Management, LLC and may be deemed to be beneficially owned by Axial Capital Management, LLC as the investment manager of such private investment vehicles. The reported securities may also be deemed to be beneficially owned by Marc Andersen and Eliav Assouline as the Managing Members of Axial Capital Management LLC. Each such Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.